Patents Assigned to Seres Therapeutics, Inc.
-
Patent number: 11918612Abstract: Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: GrantFiled: January 28, 2022Date of Patent: March 5, 2024Assignee: Seres Therapeutics, Inc.Inventors: Matthew R. Henn, Kevin Daniel Litcofsky, Anthony Mario D'Onofrio, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Geoffrey Von Maltzahn, David N. Cook, David Arthur Berry, Noubar B. Afeyan, John Grant Aunins
-
Publication number: 20240050490Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.Type: ApplicationFiled: July 11, 2023Publication date: February 15, 2024Applicant: Seres Therapeutics, Inc.Inventors: Gregory MCKENZIE, Mary-Jane LOMBARDO MCKENZIE, David N. COOK, Marin VULIC, Geoffrey VON MALTZAHN, Brian GOODMAN, John Grant AUNINS, Matthew R. HENN, David Arthur BERRY, Jonathan WINKLER
-
Publication number: 20240000859Abstract: Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with immune suppression, including infections and/or GvHD, for example, in HSCT subjects. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.Type: ApplicationFiled: November 24, 2021Publication date: January 4, 2024Applicant: Seres Therapeutics, Inc.Inventors: Matthew R. HENN, Edward J. O'BRIEN, Ambar PIÑA, Marin VULIC, Christopher B. FORD, Asuncion MARTINEZ, Divya BALASUBRAMANIAN, Elizabeth HALVORSEN, Karen KIESER, Mahmoud SALEH, Mary-Jane LOMBARDO, Sumon DATTA, Madhumitha NANDAKUMAR, Priyanka NARENDAR, Kankana BARDHAN
-
Patent number: 11730775Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.Type: GrantFiled: April 5, 2021Date of Patent: August 22, 2023Assignee: Seres Therapeutics, Inc.Inventors: Gregory McKenzie, Mary-Jane Lombardo McKenzie, David N. Cook, Marin Vulic, Geoffrey Von Maltzahn, Brian Goodman, John Grant Aunins, Matthew R. Henn, David Arthur Berry, Jonathan Winkler
-
Publication number: 20230226126Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: ApplicationFiled: October 5, 2022Publication date: July 20, 2023Applicant: Seres Therapeutics, Inc.Inventors: Matthew R. HENN, Geoffrey von MALTZAHN, Anthony Mario D'ONOFRIO, Kevin Daniel LITCOFSKY, David Arthur BERRY, David N. COOK, Noubar B. AFEYAN, John Grant AUNINS
-
Patent number: 11701394Abstract: The invention provides compositions and methods for use in the treatment and prevention of cholestatic diseases.Type: GrantFiled: August 14, 2018Date of Patent: July 18, 2023Assignee: Seres Therapeutics, Inc.Inventors: Madhumitha Nandakumar, Alice Peiyu Liou, Elizabeth Moritz Halvorsen, Gregory McKenzie, Edward J. O'Brien, David Cook
-
Patent number: 11666612Abstract: Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.Type: GrantFiled: January 4, 2021Date of Patent: June 6, 2023Assignee: Seres Therapeutics, IncInventors: Matthew R. Henn, David N. Cook, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Kevin D. Litcofsky, Han Zhang, John Grant Aunins, David Arthur Berry
-
Publication number: 20230125810Abstract: Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with dysbiosis of a gastrointestinal tract. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.Type: ApplicationFiled: November 25, 2020Publication date: April 27, 2023Applicant: Seres Therapeutics, Inc.Inventors: Asuncion MARTINEZ, Edward J. O'BRIEN, Sheri Lynn SIMMONS, David COOK, Matthew R. HENN, Christopher B. FORD, Divya BALASUBRAMANIAN, Ambar PIÑA, Liyang DIAO, Meghan CHAFEE, Marin VULIC, Madhumitha NANDAKUMAR, Sumon DATTA, Lata JAYARAMAN
-
Patent number: 11464812Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: GrantFiled: December 14, 2020Date of Patent: October 11, 2022Assignee: Seres Therapeutics, Inc.Inventors: Matthew R. Henn, Geoffrey von Maltzahn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook, Noubar B. Afeyan, John Grant Aunins
-
Patent number: 11458173Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: GrantFiled: December 14, 2020Date of Patent: October 4, 2022Assignee: Seres Therapeutics, Inc.Inventors: Matthew R. Henn, Geoffrey von Maltzahn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook, Noubar B. Afeyan, John Grant Aunins
-
Patent number: 11458174Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: GrantFiled: December 14, 2020Date of Patent: October 4, 2022Assignee: Seres Therapeutics, Inc.Inventors: Matthew R. Henn, Geoffrey von Maltzahn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook, Noubar B. Afeyan, John Grant Aunins
-
Publication number: 20220257674Abstract: Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: ApplicationFiled: January 28, 2022Publication date: August 18, 2022Applicant: Seres Therapeutics, Inc.Inventors: Matthew R. HENN, Kevin Daniel LITCOFSKY, Anthony Mario D'ONOFRIO, Toshiro K. OHSUMI, Mary-Jane Lombardo MCKENZIE, Geoffrey VON MALTZAHN, David N. COOK, David Arthur BERRY, Noubar B. AFEYAN, John Grant AUNINS
-
Publication number: 20220249578Abstract: Compositions for methods of preventing or reducing pathogenic bacterial growth, proliferation, and/or colonization are described containing one or more types of non-pathogenic bacteria to be introduced into the gastrointestinal tract and effectively compete with pathogenic bacteria for monomeric or polymeric carbohydrate nutrients, and/or amino acid nutrients, and/or vitamin nutrients.Type: ApplicationFiled: November 23, 2021Publication date: August 11, 2022Applicant: Seres Therapeutics, Inc.Inventors: David N. Cook, Han Zhang, Anthony Mario D'Onofrio, David Arthur Berry, Mary-Jane Lombardo McKenzie, John Grant Aunins, Gregory McKenzie, Toshiro K. Ohsumi
-
Patent number: 11389490Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: GrantFiled: December 14, 2020Date of Patent: July 19, 2022Assignee: Seres Therapeutics, Inc.Inventors: Matthew R. Henn, Geoffrey von MALTZAHN, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook, Noubar B. Afeyan, John Grant Aunins
-
Patent number: 11266699Abstract: Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.Type: GrantFiled: December 21, 2018Date of Patent: March 8, 2022Assignee: Seres Therapeutics, Inc.Inventors: Matthew R. Henn, Kevin Daniel Litcofsky, Anthony Mario D'Onofrio, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Geoffrey von Maltzahn, David N. Cook, David Arthur Berry, Noubar B. Afeyan, John Grant Aunins
-
Publication number: 20220017853Abstract: Provided herein are compositions and formulations that are useful for stabilizing one or more bacteria (e.g., through drying). Methods of stabilizing the one or more bacteria are also disclosed.Type: ApplicationFiled: December 5, 2019Publication date: January 20, 2022Applicant: Seres Therapeutics, Inc.Inventors: Robert K. EVANS, Carl Michael PHILBROOK, Brian Michael SCHUSTER, Lisa MARSHALL
-
Patent number: 11185562Abstract: Compositions for methods of preventing or reducing pathogenic bacterial growth, proliferation, and/or colonization are described containing one or more types of non-pathogenic bacteria to be introduced into the gastrointestinal tract and effectively compete with pathogenic bacteria for monomeric or polymeric carbohydrate nutrients, and/or amino acid nutrients, and/or vitamin nutrients.Type: GrantFiled: February 4, 2014Date of Patent: November 30, 2021Assignee: Seres Therapeutics, Inc.Inventors: David N. Cook, Han Zhang, Anthony Mario D'Onofrio, David Arthur Berry, Mary-Jane Lombardo McKenzie, John Grant Aunins, Gregory McKenzie, Toshiro K. Ohsumi
-
Publication number: 20210299191Abstract: Provided are defined bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for populating the gastrointestinal tract of a subject. Provided also are bacterial formulations for oral or gastric administration to a mammalian subject in an effective amount for prevention or treatment of a gastrointestinal disease, disorder or condition.Type: ApplicationFiled: April 12, 2021Publication date: September 30, 2021Applicant: Seres Therapeutics, Inc.Inventors: Noubar B. AFEYAN, Mary-Jane LOMBARDO MCKENZIE, Kevin Daniel LITCOFSKY, David N. COOK, Matthew R. HENN, Geoffrey VON MALTZAHN
-
Publication number: 20210252079Abstract: Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.Type: ApplicationFiled: January 4, 2021Publication date: August 19, 2021Applicant: Seres Therapeutics, Inc,Inventors: Matthew R. HENN, David N. COOK, Toshiro K. OHSUMI, Mary-Jane Lombardo MCKENZIE, Kevin D. LITCOFSKY, Han ZHANG, John Grant AUNINS, David Arthur BERRY
-
Publication number: 20210244774Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.Type: ApplicationFiled: April 5, 2021Publication date: August 12, 2021Applicant: Seres Therapeutics, Inc,Inventors: Gregory MCKENZIE, Mary-Jane LOMBARDO MCKENZIE, David N. COOK, Marin VULIC, Geoffrey VON MALTZAHN, Brian GOODMAN, John Grant AUNINS, Matthew R. HENN, David Arthur BERRY, Jonathan WINKLER